Program of vascular evaluation under glucose control by DPP-4 inhibitor.
Phase of Trial: Phase III
Latest Information Update: 15 May 2017
At a glance
- Drugs Sitagliptin (Primary) ; Antihyperglycaemics
- Indications Atherosclerosis
- Focus Therapeutic Use
- Acronyms PROLOGUE
- 15 May 2017 Status changed from active, no longer recruiting to completed.
- 16 Nov 2016 Results of sub analysis assessing effect of sitagliptin on echocardiographic systolic and diastolic parameters and N-terminal pro brain natriuretic peptide, presented at the 89th Annual Scientific Sessions of the American Heart Association
- 02 Nov 2012 Planned number of patients changed from 1200 to 500 as reported by University Hospital Medical Information Network - Japan.